SCTX

SCRIBE THERAPEUTICS INC

• Seeking Alpha·3d ago

  Cathie Wood's weekly recap: adds to CoreWeave, Meta, Recursion; cuts Personalis, Toast

• Seeking Alpha·10/15 13:06

  Scribe Therapeutics: Underrated In-Vivo Gene Therapy Developer With Near-Term Catalyst

• Benzinga·10/14 14:02

  Bending Spoons, Liquidia, Verastem And Other Big Stocks Moving Higher On Wednesday

• Benzinga·10/06 15:46

  Cathie Wood's $22M Biotech Shuffle, Dumps One Stock for 21st Straight Session While Other Bets Pile Up

• Benzinga·09/30 17:06

  12 Health Care Stocks Moving In Wednesday's Intraday Session

• Seeking Alpha·09/28 11:30

  Cathie Wood's Ark Invest weekly recap: boosts Meta, Rocket Lab; cuts Tempus AI, CrowdStrike

• Seeking Alpha·09/27 12:30

  Scribe Surges On IPO Debut -- But All Eyes Turn To 1H27 Data

• TipRanks·09/24 00:20

  Cathie Wood’s ARK Investment buys 143.3K shares of Scribe Therapeutics today

• Benzinga·09/22 14:40

  Cathie Wood Loads Up On Biotech: 5 ETFs Holding Her Latest Bets

• Benzinga·09/22 12:06

  12 Health Care Stocks Moving In Tuesday's Pre-Market Session

• Seeking Alpha·09/21 11:05

  Cathie Wood's weekly recap: buys $25M of CoreWeave, trims $40M in Bitcoin ETF

• Seeking Alpha·09/14 11:10

  Cathie Wood's Ark weekly recap: buys Meta, gene-editing stocks while cutting Alphabet

• TipRanks·09/08 10:20

  Wall Street Analysts Are Bullish on Top NA Picks

• Seeking Alpha·09/07 11:10

  Cathie Wood's weekly recap: loads Rocket Lab, Block; cuts Palantir, Tempus AI

• Dow Jones·09/03 11:24

  Scribe Therapeutics Inc Price Target Maintained With a $60.00/Share by HC Wainwright & Co.